SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The March 2024 quarter revenue stood at Rs. 2199.38 millions, up 18.00% as compared to Rs. 1863.84 millions during the corresponding quarter last year.Modest increase of 18.12% in the Net Profit was reported from. 271.58 millions to Rs. 320.80  millions.Operating profit for the quarter ended March 2024 rose to 487.07 millions as compared to 406.44 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 2199.38 1863.84 18.00 6875.83 6167.34 11.49 6875.83 6167.34 11.49
Other Income 85.54 -1.74 -5016.09 137.86 43.20 219.12 137.86 43.20 219.12
PBIDT 487.07 406.44 19.84 1214.53 1269.82 -4.35 1214.53 1269.82 -4.35
Interest 20.56 5.94 246.13 58.94 24.14 144.16 58.94 24.14 144.16
PBDT 466.51 400.50 16.48 838.05 1245.68 -32.72 838.05 1245.68 -32.72
Depreciation 43.63 34.27 27.31 146.94 123.42 19.06 146.94 123.42 19.06
PBT 422.88 366.23 15.47 691.11 1122.26 -38.42 691.11 1122.26 -38.42
TAX 102.08 94.65 7.85 254.25 288.82 -11.97 254.25 288.82 -11.97
Deferred Tax 29.02 5.96 386.91 45.12 25.05 80.12 45.12 25.05 80.12
PAT 320.80 271.58 18.12 436.86 833.44 -47.58 436.86 833.44 -47.58
Equity 368.81 364.37 1.22 368.81 364.37 1.22 368.81 364.37 1.22
PBIDTM(%) 22.15 21.81 1.56 17.66 20.59 -14.21 17.66 20.59 -14.21

Acutaas Chemicals Share Price

2401.00 39.25 (1.66%)
20-Apr-2026 14:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.90
Dr. Reddys Lab 1233.00
Cipla 1230.95
Zydus Lifesciences 937.65
Lupin 2326.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×